scholarly journals Psychometric Properties of the PHQ-9, HADS, and CES-D Questionnaires and the Prevalence of Depression in Patients with Cancer Receiving Radiotherapy

2021 ◽  
Vol 73 (12) ◽  
pp. 793-800
Author(s):  
Kantanut Yutrirak ◽  
Woraphat Ratta-apha ◽  
Pittaya Dankulchai ◽  
Panate Pukrittayakamee
Keyword(s):  
Psychometric Properties ◽  
Cancer Patients ◽  
Somatic Symptom ◽  
Depression Scale ◽  
Epidemiologic Studies ◽  
Depression Subscale ◽  
Sum Score ◽  
Prevalence Of Depression ◽  
Patient Health ◽  
Score Method

Objective: The primary aim was to compare the psychometric properties among the Patient Health Questionnaire (PHQ-9) (both including and excluding somatic symptom items), the depression subscale of the Hospital Anxiety and Depression Scale (HADS-D), and the Center for Epidemiologic Studies Depression Scale (CES-D) in detecting depression in cancer patients receiving radiotherapy. The secondary aim was to investigate the prevalence of depression in this group of patients.Materials and Methods: Overall, 198 participants with cancer diagnosis from a radiology clinic took part in the study. They completed PHQ-9, HADS-D, and CES-D questionnaires and were interviewed in line with the Mini-International Neuropsychiatric Interview (M.I.N.I.) to confirm the diagnosis. The PHQ-9 was analyzed for three scoring methods: sum-score, inclusive (including all items), and exclusive (excluding 4 somatic symptom items) methods. The psychometric properties of each questionnaire were analyzed. The prevalence of depression measured by the M.I.N.I. was evaluated.Results: The sum-score method of the PHQ-9 had an equal sensitivity (100%) to the HADS-D and CES-D, and had a slightly higher specificity (91.1%) than the HADS-D (87.4%) and CES-D (90.6%). When compared results within the PHQ-9, the sum-score method had greater sensitivity than the inclusive (71.4%) and exclusive (42.9%) methods, and had a slightly lower specificity than the inclusive (96.9%) and exclusive (97.4%) methods. The prevalence of depression assessed by the M.I.N.I was 3.5%.Conclusion: The sum-score method of the PHQ-9 seemed to be the best tool to use for depression screening in cancer patients receiving radiotherapy due to its excellent sensitivity and specificity.

Psychometric Properties of the Dutch Version of the Signs of Depression Scale

2016 ◽  
Vol 27 (5) ◽  
pp. 617-637 ◽  
Author(s):  
Mariska J. van Dijk ◽  
Janneke M. de Man-van Ginkel ◽  
Thóra B. Hafsteinsdóttir ◽  
Marieke J. Schuurmans
Keyword(s):  
Psychometric Properties ◽  
Intraclass Correlation ◽  
Depression Scale ◽  
Cross Sectional Study ◽  
Cutoff Score ◽  
Stroke Patients ◽  
Dutch Version ◽  
Cross Sectional ◽  
Symptoms Of Depression ◽  
Patient Health

The early detection of depression after stroke is essential for the optimization of recovery in aphasic stroke patients. The purpose of this study was to evaluate the psychometric properties of the Signs of Depression Scale (SODS), a non-language-based screening instrument. We conducted a cross-sectional study in a sample of 58 stroke patients in a rehabilitation center. The internal consistency and interrater reliability were good (α = .71 and intraclass correlation coefficient [ICC] = .79). The pre-defined hypotheses confirmed the construct validity, and the correlation between the SODS and the Patient Health Questionnaire–9 (PHQ-9) was moderate ( rb = .32). At a cutoff score of ≥1, the sensitivity was 0.80, and the specificity was 0.39. These findings indicate that the SODS is appropriate to screen for depressive symptoms and can be used by nurses to identify symptoms of depression in patients with aphasia who require further assessment.

scholarly journals Does your neighborhood protect you from being depressed? A study on social trust and depression in Indonesia

2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Mohamad Fahmi ◽  
Nur Afni Panjaitan ◽  
Ibnu Habibie ◽  
Adiatma Y. M. Siregar ◽  
Gilang Amarullah ◽  
...  
Keyword(s):  
Social Trust ◽  
Depression Scale ◽  
Severe Depression ◽  
Total Sample ◽  
Epidemiologic Studies ◽  
Depression Symptoms ◽  
Multilevel Regression ◽  
Individual Level ◽  
Prevalence Of Depression ◽  
The Individual

Abstract Background Prevalence of depression in Indonesia is estimated at about 3.7% of the total population, although the actual may be higher. Studies worldwide have linked the environment where people live to their mental health status. However, little research is found in Indonesia regarding this link. We examined the association between individuals’ perception towards their neighborhood and their depression symptoms. Methods Social trust was measured at the individual (level 1) and community (level 2) levels based on the Indonesian Family Life Survey 5 (IFLS5) in 2014. Depression was measured using the 10-item Center for Epidemiologic Studies-Depression Scale Revised (CESD-R-10) and the scores were transformed into logit form using the Rasch model. Multilevel regression was used to determine correlations. Results Of the total sample of 14,227 respondents in this study, about 19.4% had experienced severe depression symptoms in the past week. Social trust was found to be significantly associated with severe depression symptoms. The weaker the individuals’ social trust towards their neighbourhood, the higher the probability of experiencing severe depression symptoms would be. Conclusions This study shows that social trust is associated with the severity of depression symptoms: the higher the social trust, the lower the probability of having severe depression symptoms is. Depression symptoms may also be attributed to significant differences between communities.

Absence of major depressive disorder in female cancer patients.

1985 ◽  
Vol 3 (11) ◽  
pp. 1553-1560 ◽  
Author(s):  
S B Lansky ◽  
M A List ◽  
C A Herrmann ◽  
E G Ets-Hokin ◽  
T K DasGupta ◽  
...  
Keyword(s):  
Cancer Patients ◽  
Rating Scale ◽  
Performance Status ◽  
Depression Scale ◽  
Current Treatment ◽  
Karnofsky Performance Scale ◽  
Prevalence Of Depression ◽  
History Of ◽  
Highly Correlated ◽  
History Of Depression

This investigation evaluated the prevalence of depression in female patients who had cancer in any of five predesignated sites. Five hundred five women aged 17 to 80 (190 with breast cancer, 143 with gynecologic malignancies, 111 with melanoma, 37 with bowel cancer, and 24 with lymphoma) were randomly screened. Assessment included the Hamilton rating scale for depression, the Zung self-rating depression scale, the Karnofsky performance scale, and a 10-cm visual pain analogue line. The results revealed a mean Hamilton of 10.2 (range, 0 to 41; SD, 7.5), a mean Zung score of 35.3 (range, 11 to 68; SD, 9.6), a Karnofsky median score of 80, and a median pain score of 0. Scores on the Zung scale were highly correlated with those of the Hamilton scale (r = .75). Based on cutoff scores accepted as indicating depression (Hamilton greater than or equal to 20 and Zung greater than or equal to 50), patients were depressed. The depressed subgroup was in significantly more pain, experienced greater physical disability, and was more likely to have had prior episodes of depression as compared to the non-depressed women. The two best predictors of current depression were performance status (Karnofsky) and history of depression. No relationship was found between depression and other demographic variables or disease parameters (diagnosis, time since diagnosis, stage or phase of illness, and current treatment). Our findings indicate that the prevalence of major depression in cancer patients is lower than many previous studies have indicated and falls within the range seen in the general population.

The WHO-5 Well-Being Index: A Validation Study in People with Infertility

2020 ◽  
Author(s):  
Reza OMANI-SAMANI ◽  
Saman MAROUFIZADEH ◽  
Amir ALMASI-HASHIANI ◽  
Mahdi SEPIDARKISH ◽  
Payam AMINI
Keyword(s):  
Internal Consistency ◽  
Convergent Validity ◽  
Depression Scale ◽  
Reliability And Validity ◽  
Public Health Problem ◽  
Well Being ◽  
Cronbach’S Alpha ◽  
Cronbach's Alpha ◽  
Prevalence Of Depression ◽  
Patient Health

Background: Infertility is a public health problem and can lead to depressive symptoms. In recent years, the WHO-five Well-being Index (WHO-5) has been used as a screening measure for depression, but study on psychometric properties in people with infertility is scarce. The objective of this study was to examine the reliability and validity of the Persian version of the WHO-5 in people with infertility. Methods: Overall, 539 infertile patients from a referral infertility center in Tehran, Iran in the period between May and Aug 2017, completed the WHO-5, along with other psychological measures: the Patient Health Questionnaire-9 (PHQ-9) and the Hospital Anxiety and Depression Scale (HADS). Construct validity and internal consistency of WHO-5 were evaluated using confirmatory factor analysis (CFA) and Cronbach’s alpha, respectively. Convergent validity was examined by relationship with PHQ-9 and HADS. Results: The prevalence of poor well-being was 44.3% and that of depression was 18.6%. CFA confirmed the unidimensional factor structure of the WHO-5. Internal consistency of the WHO-5 was good (Cronbach’s alpha=0.858). The WHO-5 significantly correlated with the PHQ-9 (r=-0.522), HADS-anxiety (r=-0.524) and HADS-depression (r=-0.630), confirming convergent validity. Conclusion: The WHO-5 is a short and easy to use questionnaire with satisfactory reliability and validity that appears suitable for use as a screening test for depressive symptom in infertile people. In addition, the prevalence of depression and poor well-being was very high in this population.

Prevalence of depression among relatives of cancer patients in Jordan: A cross-sectional survey

2011 ◽  
Vol 9 (1) ◽  
pp. 25-29 ◽  
Author(s):  
Nizar M. Mhaidat ◽  
Suleiman A. Ai-Sweedan ◽  
Karem H. Alzoubi ◽  
Sayer I. Alazzam ◽  
Mohammed N. Banihani ◽  
...  
Keyword(s):  
Cancer Patients ◽  
Depression Scale ◽  
Chronically Ill ◽  
University Hospital ◽  
Psychological Status ◽  
Disease Stage ◽  
Psychological State ◽  
Cross Sectional Survey ◽  
Cross Sectional ◽  
Prevalence Of Depression

AbstractObjective:Depression is common among chronically ill patients and their relatives. In this article, we investigated the prevalence of depression among relatives of cancer patients in Jordan, and studied the relation between several socio-demographic, disease- and treatment-related factors, together with the occurrence of depression among those relatives.Method:A cross-sectional survey study was conducted at a major university hospital in Jordan. Relatives of cancer patients were interviewed for socio-demographic information, and medical records were checked for information about disease and treatment of patient. Psychological status of the relative was assessed using the Hospital Anxiety & Depression Scale (HADS).Results:The prevalence of depression in our sample was 81.9%. Age and degree of relatedness were significantly correlated with the occurrence of depression among relatives of cancer patients. Significant correlations were also detected between depression among patient's relatives and the stage of the disease. Positive predictive factors for depression included relatives being middle aged, close relatedness, patients being in advanced disease stage, and on chemotherapy or undergoing surgery for cancer treatment.Significance of results:Depression is prevalent among relatives of cancer patients. Therefore, more attention is needed to detect changes in the psychological state of vulnerable relatives of cancer patients, in an effort to reduce the occurrence of depression.

scholarly journals Psychometric properties of the PHQ-9 depression scale in people with multiple sclerosis: a systematic review

2018 ◽  
Author(s):  
Sarah Patrick ◽  
Peter Connick
Keyword(s):  
Multiple Sclerosis ◽  
Psychometric Properties ◽  
Depression Scale ◽  
Assessment Tools ◽  
Patient Health Questionnaire ◽  
Health Questionnaire ◽  
Eligibility Criteria ◽  
Retest Reliability ◽  
Patient Health ◽  
Test Retest Reliability

AbstractBackgroundDepression affects approximately 25% of people with MS (pwMS) at any given time. It is however under recognised in clinical practice, in part due to a lack of uptake for brief assessment tools and uncertainty about their psychometric properties. The 9-item Patient Health Questionnaire (PHQ-9) is an attractive candidate for this role.ObjectiveTo synthesise published findings on the psychometric properties of the 9-item Patient Health Questionnaire (PHQ-9) when applied to people with multiple sclerosis (pwMS).Data sourcesPubMed, Medline and ISI Web of Science databases, supplemented by hand-searching of references from all eligible sources.Study eligibility criteriaPrimary literature written in English and published following peer-review with a primary aim to evaluate the performance of the PHQ-9 in pwMS.Outcome measuresPsychometric performance with respect to appropriateness, reliability, validity, responsiveness, precision, interpretability, acceptability, and feasibility.ResultsSeven relevant studies were identified, these were of high quality and included 5080 participants from all MS disease-course groups. Strong evidence was found supporting the validity of the PHQ-9 as a unidimensional measure of depression. Used as a screening tool for major depressive disorder (MDD) with a cut-point of 11, sensitivity was 95% sensitivity and specificity 88.3% (PPV 51.4%, NPV 48.6%). Alternative scoring systems that may address the issue of overlap between somatic features of depression and features of MS per se are being developed, although their utility remains unclear. However data on reliability was limited, and no specific evidence was available on test-retest reliability, responsiveness, acceptability, or feasibility.ConclusionsThe PHQ-9 represents a suitable tool to screen for MDD in pwMS. However use as a diagnostic tool cannot currently be recommended, and the potential value for monitoring depressive symptoms cannot be established without further evidence on test-retest reliability, responsiveness, acceptability, and feasibility.PROSPERO register ID: CRD42017067814

Sign in / Sign up

Export Citation Format

Share Document